Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Cost-effectiveness of Voretigene Neparvovec-rzyl Therapy

Cost-effectiveness of Voretigene Neparvovec-rzyl Therapy Cost-effectiveness of Voretigene Neparvovec-rzyl vs Standard Care for RPE65-Mediated Retinal Disease Original Investigation Research treatment on health states and ambulatory 31. Sanders GD, Neumann PJ, Basu A, et al. November 13, 2017. https://icer-review.org/wp- function in patients with hypophosphatasia Recommendations for conduct, methodological content/uploads/2017/06/MWCEPAC_ [abstract SUO334]. In: 2017 Abstracts: 2017 practices, and reporting of cost-effectiveness VORETIGENE_DRAFT_EVIDENCE_REPORT_ Meeting of the American Society for Bone and analyses: second panel on cost-effectiveness in 11152017.pdf. Published December 11, 2017. Mineral Research, 2017:S282. health and medicine. JAMA. 2016;316(10):1093-1103. Accessed June 14, 2019. doi:10.1001/jama.2016.12195 26. Brown MM, Brown GC, Sharma S, Landy J. 37. Caro JJ, Briggs AH, Siebert U, Kuntz KM; Health care economic analyses and value-based 32. Sharma S, Oliver-Fernandez A, Bakal J, ISPOR-SMDM Modeling Good Research Practices medicine. Surv Ophthalmol. 2003;48(2):204-223. Hollands H, Brown GC, Brown MM. Utilities Task Force. Modeling good research doi:10.1016/S0039-6257(02)00457-5 associated with diabetic retinopathy: results from a practices—overview: a report of the ISPOR-SMDM Canadian sample. Br J Ophthalmol. 2003;87(3): Modeling Good Research Practices Task Force-1. 27. Brown MM, Brown GC, Lieske HB, Tran I, 259-261. doi:10.1136/bjo.87.3.259 Med Decis Making. 2012;32(5):667-677. doi:10.1177/ Turpcu A, Colman S. Societal costs associated with 0272989X12454577 neovascular age-related macular degeneration in 33. Chambers JD, Thorat http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Ophthalmology American Medical Association

Cost-effectiveness of Voretigene Neparvovec-rzyl Therapy

JAMA Ophthalmology , Volume 137 (10) – Oct 18, 2019

Loading next page...
 
/lp/american-medical-association/cost-effectiveness-of-voretigene-neparvovec-rzyl-therapy-iRwvoEE3zj
Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
2168-6165
eISSN
2168-6173
DOI
10.1001/jamaophthalmol.2019.2517
Publisher site
See Article on Publisher Site

Abstract

Cost-effectiveness of Voretigene Neparvovec-rzyl vs Standard Care for RPE65-Mediated Retinal Disease Original Investigation Research treatment on health states and ambulatory 31. Sanders GD, Neumann PJ, Basu A, et al. November 13, 2017. https://icer-review.org/wp- function in patients with hypophosphatasia Recommendations for conduct, methodological content/uploads/2017/06/MWCEPAC_ [abstract SUO334]. In: 2017 Abstracts: 2017 practices, and reporting of cost-effectiveness VORETIGENE_DRAFT_EVIDENCE_REPORT_ Meeting of the American Society for Bone and analyses: second panel on cost-effectiveness in 11152017.pdf. Published December 11, 2017. Mineral Research, 2017:S282. health and medicine. JAMA. 2016;316(10):1093-1103. Accessed June 14, 2019. doi:10.1001/jama.2016.12195 26. Brown MM, Brown GC, Sharma S, Landy J. 37. Caro JJ, Briggs AH, Siebert U, Kuntz KM; Health care economic analyses and value-based 32. Sharma S, Oliver-Fernandez A, Bakal J, ISPOR-SMDM Modeling Good Research Practices medicine. Surv Ophthalmol. 2003;48(2):204-223. Hollands H, Brown GC, Brown MM. Utilities Task Force. Modeling good research doi:10.1016/S0039-6257(02)00457-5 associated with diabetic retinopathy: results from a practices—overview: a report of the ISPOR-SMDM Canadian sample. Br J Ophthalmol. 2003;87(3): Modeling Good Research Practices Task Force-1. 27. Brown MM, Brown GC, Lieske HB, Tran I, 259-261. doi:10.1136/bjo.87.3.259 Med Decis Making. 2012;32(5):667-677. doi:10.1177/ Turpcu A, Colman S. Societal costs associated with 0272989X12454577 neovascular age-related macular degeneration in 33. Chambers JD, Thorat

Journal

JAMA OphthalmologyAmerican Medical Association

Published: Oct 18, 2019

References